Acher C W, Belzer F O, Grist T M, Turnipseed W D, Hoch J R, Archibald J E
Department of Surgery, University of Wisconsin, Madison, USA.
Cardiovasc Surg. 1996 Oct;4(5):602-6. doi: 10.1016/0967-2109(95)00034-8.
Long-term outcome was studied in 233 patients who had undergone renal artery revascularization (51 with balloon angioplasty, 182 with surgery) between 1976 and 1992. Patients (excluding renal transplants) were treated for renal vascular hypertension without or with renal insufficiency (serum creatinine > 1.6 mg/dl. All patients still alive (n = 188) were contacted to determine current blood pressure, medications, serum creatinine, and subsequent significant medical events. In patients who had died the cause of death was determined and renal function status at the time of death noted from medical records. Some follow-up information was obtained on all 233 patients; follow-up serum creatinine data were obtained in 193 (82.8%) patients. Some 24 patients (10.3%) became dialysis-dependent. Using a multiple logistic regression analysis only, preoperative creatinine maintained significance (P < 0.001) for increased dialysis risk. There was no statistically significant association of dialysis for type of revascularization (percutaneous transluminal angioplasty, autogenous artery, saphenous vein, endarterectomy or synthetic material), simultaneous or previous aortic or other vascular surgery (carotid endarterectomy, femoropopliteal bypass, etc.), pathology (atherosclerosis or fibromuscular dysplasia), number of renal arteries stenosed or treated, length of follow-up, age, coronary artery disease, congestive heart failure, stroke, chronic lung disease or type II diabetes. It is concluded that, in patients with renal artery stenosis, the timing of renal artery revascularization relative to the level of renal function is the most important determinant for long-term renal salvage.
对1976年至1992年间接受肾动脉血运重建术的233例患者(51例行球囊血管成形术,182例行手术)的长期预后进行了研究。患者(不包括肾移植患者)因肾血管性高血压接受治疗,有无肾功能不全(血清肌酐>1.6mg/dl)。联系了所有仍存活的患者(n = 188),以确定当前血压、用药情况、血清肌酐以及随后发生的重大医疗事件。对于已死亡的患者,确定死亡原因,并从病历中记录死亡时的肾功能状态。获取了所有233例患者的一些随访信息;193例(82.8%)患者获得了随访血清肌酐数据。约24例患者(10.3%)开始依赖透析。仅使用多元逻辑回归分析,术前肌酐水平对透析风险增加仍具有显著意义(P < 0.001)。血运重建类型(经皮腔内血管成形术、自体动脉、大隐静脉、动脉内膜切除术或合成材料)、同期或既往主动脉或其他血管手术(颈动脉内膜切除术、股腘动脉旁路移植术等)、病理类型(动脉粥样硬化或纤维肌性发育不良)、狭窄或接受治疗的肾动脉数量、随访时间、年龄、冠状动脉疾病、充血性心力衰竭、中风、慢性肺部疾病或II型糖尿病与透析之间均无统计学显著关联。得出的结论是,在肾动脉狭窄患者中,肾动脉血运重建相对于肾功能水平的时机是长期挽救肾脏的最重要决定因素。